{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:23:38Z","timestamp":1761488618471},"reference-count":77,"publisher":"American Society of Consultant Pharmacists","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Consultant Pharmacist"],"published-print":{"date-parts":[[2006,7,1]]},"DOI":"10.4140\/tcp.n.2006.563","type":"journal-article","created":{"date-parts":[[2011,1,12]],"date-time":"2011-01-12T21:09:19Z","timestamp":1294866559000},"page":"563-575","source":"Crossref","is-referenced-by-count":16,"title":["Dementia with Lewy Bodies: Therapeutic Opportunities and Pitfalls"],"prefix":"10.4140","volume":"21","author":[{"given":"Anne-Lenora","family":"Henriksen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarke","family":"St. Dennis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Setter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John T.","family":"Tran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2625","published-online":{"date-parts":[[2009,7,2]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop","volume":"47","author":"I McKeith","year":"1996","journal-title":"Neurology"},{"key":"2","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1212\/WNL.53.5.902","article-title":"Report of the Second Dementia with Lewy Body International Workshop: diagnosis and treatment","volume":"53","author":"I McKeith","year":"1999","journal-title":"Neurology"},{"key":"3","first-page":"131","article-title":"Dementia with Lewy bodies\u2014diagnosis and treatment","volume":"133","author":"U Mosimann","year":"2003","journal-title":"Swiss Med Wkly"},{"key":"4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00005072-196104000-00007","article-title":"Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion","volume":"20","author":"H Okazaki","year":"1961","journal-title":"J Neuropathol Exp Neurol"},{"key":"5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/jnnp.52.1.67","article-title":"Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease","volume":"52","author":"G Lennox","year":"1989","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/brain\/118.6.1447","article-title":"Ubiquitin-positive degenerating neurites in the brainstem in Parkinson's disease","volume":"116","author":"W Gai","year":"1995","journal-title":"Brain"},{"key":"7","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the \u03b1-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"M Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000074677","article-title":"Pathology and neurotransmitter abnormalities of dementia with Lewy bodies.","volume":"17","author":"J Duda","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"key":"9","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnen\/62.8.812","article-title":"\u03b1-Synuclein accumulates in purkinje cells in Lewy body disease but not in multiple system atrophy","volume":"62","author":"F Mori","year":"2003","journal-title":"J Neuropathol Exp Neurology"},{"key":"10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0304-3940(99)00208-6","article-title":"Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by \u03b1-synuclein immunocytochemistry","volume":"265","author":"H Braak","year":"1999","journal-title":"Neurosci Lett"},{"key":"11","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/00005072-199311000-00012","article-title":"Plaque-only Alzheimer disease is usually the Lewy body variant, and vice versa","volume":"52","author":"L Hansen","year":"1993","journal-title":"J Neuropathol Exp Neurol"},{"key":"12","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/WNL.54.10.1916","article-title":"\u03b1-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease","volume":"54","author":"H Hurtig","year":"2000","journal-title":"Neurology"},{"key":"13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00002093-200210000-00001","article-title":"Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the state of Florida brain bank","volume":"16","author":"W Barker","year":"2002","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1192\/bjp.174.1.45","article-title":"Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies","volume":"174","author":"C Holmes","year":"1999","journal-title":"Br J Psychiatry"},{"key":"15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/sj.npp.1300302","article-title":"Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5[<sup>125<\/sup>I[-A-85380","volume":"29","author":"S Pimlott","year":"2004","journal-title":"Neuropsychopharm"},{"key":"16","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/archpsyc.59.10.946","article-title":"Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease","volume":"59","author":"P Tiraboschi","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"17","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s007020050176","article-title":"Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology","volume":"106","author":"C Lippa","year":"1999","journal-title":"J Neural Transm"},{"key":"18","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/1531-8249(200012)48:6<868::AID-ANA7>3.0.CO;2-0","article-title":"Delusions associated with elevated muscarinic binding in dementia with Lewy bodies","volume":"48","author":"C Ballard","year":"2000","journal-title":"Ann Neurol"},{"key":"19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0022-510X(01)00638-4","article-title":"Distribution of m1 muscarinic acetylcholine receptors in the hippocampus of patients with Alzheimer's disease and dementia with Lewy bodies\u2014an immunohistochemical study","volume":"193","author":"K Shiozaki","year":"2001","journal-title":"J Neurol Sci"},{"key":"20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0022-510X(90)90236-G","article-title":"Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly.","volume":"95","author":"R Perry","year":"1990","journal-title":"J Neurol Sci"},{"key":"21","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/brain\/122.8.1449","article-title":"Striatal dopaminergic markers in dementia with Lewy bodies. Alzheimer's and Parkinson's diseases: rostrocaudal distribution.","volume":"122","author":"M Piggott","year":"1999","journal-title":"Brain"},{"key":"22","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(05)78999-6","article-title":"Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease","volume":"351","author":"C Ballard","year":"1998","journal-title":"Lancet"},{"key":"23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/bmj.305.6855.673","article-title":"Neuroleptic sensitivity in patients with senile dementia of Lewy body type","volume":"305","author":"I McKeith","year":"1992","journal-title":"BMJ"},{"key":"24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1176\/jnp.5.2.206","article-title":"Clozapine use in diffuse Lewy body disease","volume":"5","author":"R Chacko","year":"1993","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1176\/jnp.10.2.227","article-title":"Neuroleptic sensitivity to clozapine in dementia with Lewy bodies","volume":"10","author":"W Burke","year":"1998","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/00019442-200301000-00019","article-title":"Coma with accidental single dose of an atypical neuroleptic in a patient with Lewy body dementia","volume":"11","author":"J Sadek","year":"2003","journal-title":"Am J Geriatr Psychiatry"},{"key":"27","doi-asserted-by":"crossref","DOI":"10.1177\/070674370204701018","article-title":"Probable dementia with Lewy bodies and risperidone-induced delirium","volume":"47","author":"M Morikawa","year":"2002","journal-title":"Can J Psychiatry"},{"key":"28","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(95)92307-1","article-title":"Neuroleptic sensitivity to risperidone in Lewy body dementia","volume":"346","author":"I McKeith","year":"1995","journal-title":"Lancet"},{"key":"29","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0278-5846(00)00123-8","article-title":"Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies","volume":"24","author":"G Sechi","year":"2000","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/(SICI)1099-1166(199801)13:1<65::AID-GPS731>3.0.CO;2-K","article-title":"Risperidol and withdrawal bruxism in Lewy body dementia","volume":"13","author":"R Shiwach","year":"1998","journal-title":"Int J Geriatr Psychiatry"},{"key":"31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0278-5846(01)00235-4","article-title":"Improvement of both psychotic symptoms and parkinsonism in a case of dementia with Lewy bodies by the combination therapy of risperidone and L-DOPA","volume":"26","author":"K Kato","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"32","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(95)91245-2","article-title":"Risperidone for psychotic and behavioural symptoms in Lewy body dementia","volume":"346","author":"R Allen","year":"1995","journal-title":"Lancet"},{"key":"33","first-page":"194","article-title":"Response of a patient with Lewy-body dementia to risperidone","volume":"15","author":"M Hussain","year":"1998","journal-title":"Adv Ther"},{"key":"34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/gps.930090511","article-title":"The use of risperidone, an atypical neuroleptic, in Lewy body disease","volume":"9","author":"H Lee","year":"1994","journal-title":"Int J Geriatr Psychiatry"},{"key":"35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000048636","article-title":"Efficacy of olanzapine in the treatment of psychosis in dementia with Lewy bodies","volume":"13","author":"J Cummings","year":"2002","journal-title":"Dement Geriatr Cogn Discord"},{"key":"36","article-title":"Reduction of psychotic symptoms by olanzapine in patients with possible Lewy body dementia","volume":"49","author":"W Clark","year":"2001","journal-title":"Schizophr Res"},{"key":"37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/(SICI)1099-1166(199906)14:6<459::AID-GPS957>3.0.CO;2-R","article-title":"Olanzapine in dementia with Lewy bodies: a clinical study","volume":"14","author":"Z Walker","year":"1999","journal-title":"Int J Geriatr Psychiatry"},{"key":"38","article-title":"The olanzapine-rivastigmine association in dementia with Lewy body disease: a case report","volume-title":"Poster: Center de Long S\u00e9jour, rue du colonel Betboy, Pontacq, France.","author":"B Placines"},{"key":"39","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0278-5846(03)00040-X","article-title":"Quetiapine treatment of psychotic symptoms and aggressive behavior in patients with dementia with Lewy bodies: a case series.","volume":"24","author":"H Takahashi","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"40","doi-asserted-by":"crossref","first-page":"513","DOI":"10.4088\/JCP.v63n0608","article-title":"Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies.","volume":"63","author":"H Fernandez","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"41","article-title":"Quetiapine in the treatment of psychosis associated with Lewy body dementia.","volume":"52","author":"A Baskys","year":"2002","journal-title":"Ann Neurol"},{"key":"42","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0920-9964(03)80429-2","article-title":"Atypical antipsychotic quetiapine in the treatment of psychosis associated with Lewy body dementia","volume":"15","author":"A Baskys","year":"2003","journal-title":"Schizophrenia Res"},{"key":"43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/10401239909147063","article-title":"Quetiapine as an alternative to clozapine in the treatment of dopamimetic psychosis in patients with Parkinson's disease","volume":"11","author":"M Menza","year":"1999","journal-title":"Ann Clin Psychiatry"},{"key":"44","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.4088\/JCP.v64n1217g","article-title":"Two case studies of quetiapine augmentation for donepezil-refractory visual hallucinations in dementia with Lewy bodies","volume":"64","author":"T Terao","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"45","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(94)90966-0","article-title":"Lewy bodies and response to tacrine in Alzheimer's disease","volume":"343","author":"R Levy","year":"1994","journal-title":"Lancet"},{"key":"46","article-title":"Failure of tacrine treatment in a case of cortical Lewy body dementia (letter)","volume":"10","author":"C Witjeratne","year":"1995","journal-title":"Int J Geriatr Psychiatry"},{"key":"47","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/(SICI)1099-1166(199808)13:8<516::AID-GPS810>3.0.CO;2-O","article-title":"Tacrine efficacy in Lewy body dementia","volume":"13","author":"F Lebert","year":"1998","journal-title":"Int J Geriatr Psychiatry"},{"key":"48","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000017260","article-title":"Allam GJ, Geffroy MA, Schiff HB, Kaplan RF. Acetylcholinesterase inhibition in dementia with Lewy bodies: results of a prospective pilot trial.","volume":"11","author":"H Querfurth","year":"2000","journal-title":"Dement Geriatr Cogn Discord"},{"key":"49","volume-title":"Pfizer Pharmaceuticals, Inc","year":"2003"},{"key":"50","first-page":"421","article-title":"Combination of risperidone and donepezil in Lewy body dementia","volume":"43","author":"M Geizer","year":"1998","journal-title":"Can J Psychiatry"},{"key":"51","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1017\/S1041610298005341","article-title":"Donepezil for treatment of dementia with Lewy bodies: a case series of nine patients","volume":"10","author":"C Shea","year":"1998","journal-title":"Int Psychogeriatr"},{"key":"52","article-title":"Dementia with Lewy bodies: response of delirium-like features to donepezil","volume":"15","author":"D Kaufer","year":"1998","journal-title":"Neurology"},{"key":"53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/(SICI)1099-1166(199901)14:1<69::AID-GPS888>3.0.CO;2-C","article-title":"Donepezil for dementia with Lewy bodies: a case study","volume":"14","author":"D Aarsland","year":"1999","journal-title":"Int J Geriatr Psychiatry"},{"key":"54","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1345\/aph.10192","article-title":"Successful use of donepezil for the treatment of dementia with Lewy bodies","volume":"32","author":"C Rojas-Fernandez","year":"2001","journal-title":"Ann Pharmacother"},{"key":"55","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/1099-1166(200012)15:12<1147::AID-GPS262>3.0.CO;2-L","article-title":"Improvement in sundowning in dementia with Lewy bodies after treatment with donepezil","volume":"15","author":"A Skjerve","year":"2000","journal-title":"Int J Geriatr Psychiatry"},{"key":"56","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/(SICI)1099-1166(200003)15:3<280::AID-GPS108>3.0.CO;2-N","article-title":"Donepezil for the treatment of psychosis in dementia with Lewy bodies","volume":"15","author":"E Fergusson","year":"2000","journal-title":"Int J Geriatr Psychiatry"},{"key":"57","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/(SICI)1099-1166(200004)15:4<338::AID-GPS119>3.0.CO;2-U","article-title":"Donepezil for behavioural disorders associated with Lewy bodies: a case series","volume":"5","author":"K Lanctot","year":"2000","journal-title":"Int J Geriatr Psychiatry"},{"key":"58","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/1099-1166(200009)15:9<794::AID-GPS178>3.0.CO;2-1","article-title":"Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study","volume":"15","author":"W Samuel","year":"2000","journal-title":"Int J Geriatr Psychiatry"},{"key":"59","article-title":"Severe worsening of parkinsonism in Lewy body dementia due to donepezil","volume":"61","author":"M Onofri","year":"2003","journal-title":"Neurology"},{"key":"60","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1212\/WNL.63.8.1543-a","article-title":"Severe worsening of parkinsonism in Lewy body dementia due to donepezil","volume":"63","author":"L Rozzini","year":"2004","journal-title":"Neurology"},{"key":"61","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/gps.995","article-title":"What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia.","volume":"18","author":"T Minett","year":"2003","journal-title":"Int J Geriatr Psychiatry"},{"key":"62","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/153331750401900411","article-title":"Alleviation of multiple abnormalities by galantamine treatment in two patients with dementia with Lewy bodies","volume":"19","author":"A Holm","year":"2004","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"63","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1185\/030079903125002054","article-title":"Clinical experience of galantamine in dementia: a series of case reports","volume":"19","author":"M Dale","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"64","doi-asserted-by":"crossref","DOI":"10.1159\/000074681","article-title":"Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 12-week interim analysis.","volume":"17","author":"K Edwards","year":"2004","journal-title":"Dement Geriatr Cog Disord"},{"key":"65","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-0447.2004.00323.x","article-title":"A case study in the treatment of dementia with Lewy bodies","volume":"110","author":"D Kaufer","year":"2004","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"66","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1176\/jnp.17.4.552","article-title":"Emergent complications following donepezil switchover to galantamine in three cases of dementia with Lewy bodies","volume":"17","author":"N Bhanji","year":"2005","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"67","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1017\/S1041610201007670","article-title":"Dementia with Lewy bodies treated with rivastigmine: effects on cognition, neuropsychiatric symptoms, and sleep","volume":"13","author":"L Maclean","year":"2001","journal-title":"Int Psychogeriatr"},{"key":"68","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(00)03399-7","article-title":"Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study","volume":"356","author":"I McKeith","year":"2000","journal-title":"Lancet"},{"key":"69","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000048651","article-title":"Effects of rivastigmine on cognitive function in dementia with Lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerized assessment system","volume":"13","author":"K Wesnes","year":"2002","journal-title":"Dement Geriatr Cog Disord"},{"key":"70","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/(SICI)1099-1166(200005)15:5<387::AID-GPS131>3.0.CO;2-9","article-title":"Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial","volume":"15","author":"I McKeith","year":"2000","journal-title":"Int J Geriatr Psychiatry"},{"key":"71","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/1099-1166(200011)15:11<1034::AID-GPS231>3.0.CO;2-5","article-title":"Dementia with Lewy bodies: findings from an international multicentre study","volume":"14","author":"S Del","year":"2000","journal-title":"Int J Geriatr Psychiatry"},{"key":"72","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1017\/S104161020100758X","article-title":"Long-term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial","volume":"13","author":"J Grace","year":"2001","journal-title":"Int Psychogeriatr"},{"key":"73","article-title":"Predicting the response to rivastigmine in dementia with Lewy bodies: the role of hallucinations.","volume":"16","author":"K Wesnes","year":"2002","journal-title":"J Psychopharmacol"},{"key":"74","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3233\/JAD-2005-8307","article-title":"Exacerbation of Lewy bodies dementia due to memantine","volume":"8","author":"M Menendez-Gonzalez","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"75","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3233\/JAD-2005-7403","article-title":"The use of memantine with dementia with Lewy bodies","volume":"7","author":"M Sabbagh","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"76","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1212\/01.wnl.0000172351.95783.8e","article-title":"Delusions and hallucinations in dementia with Lewy bodies: worsening with memantine","volume":"65","author":"B Ridha","year":"2005","journal-title":"Neurology"},{"key":"77","article-title":"Diagnostic and statistical manual of mental disorders","volume-title":"Text Revision","year":"2000"}],"container-title":["The Consultant Pharmacist"],"original-title":[],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T16:04:51Z","timestamp":1559923491000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ingentaconnect.com\/content\/ascp\/tcp\/2006\/00000021\/00000007\/art00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,1]]},"references-count":77,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,7,1]]}},"alternative-id":["C55L819641791711"],"URL":"https:\/\/doi.org\/10.4140\/tcp.n.2006.563","relation":{},"ISSN":["0888-5109"],"issn-type":[{"value":"0888-5109","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7,1]]}}}